Neurogene (NASDAQ:NGNE) Stock Rating Lowered by Robert W. Baird
Robert W. Baird cut shares of Neurogene (NASDAQ:NGNE – Free Report) from an outperform rating to a neutral rating in a research note released on Friday, Marketbeat.com reports. They currently have $24.00 price target on the stock, down from their previous price target of $38.00. A number of other research analysts have also recently weighed […]
Robert W. Baird cut shares of Neurogene (NASDAQ:NGNE – Free Report) from an outperform rating to a neutral rating in a research note released on Friday, Marketbeat.com reports. They currently have $24.00 price target on the stock, down from their previous price target of $38.00. A number of other research analysts have also recently weighed […]
